Cargando…

Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women

BACKGROUND: Alendronate has been found to reduce the risk of fractures in postmenopausal women as demonstrated in multiple randomized controlled trials enrolling thousands of women. Yet there is a paucity of such randomized controlled trials in osteoporotic men. Our objective was to systematically r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawka, Anna M, Papaioannou, Alexandra, Adachi, Jonathan D, Gafni, Amiram, Hanley, David A, Thabane, Lehana
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182376/ https://www.ncbi.nlm.nih.gov/pubmed/16008835 http://dx.doi.org/10.1186/1471-2474-6-39

Ejemplares similares

A Scoping Review of Strategies for the Prevention of Hip Fracture in Elderly Nursing Home Residents
por: Sawka, Anna M., et al.
Publicado: (2010)

Improvement in health-related quality of life in osteoporosis patients treated with teriparatide
por: Lau, Arthur N, et al.
Publicado: (2008)

Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?
por: Sawka, Anna M, et al.
Publicado: (2005)

A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma
por: Sawka, Anna M, et al.
Publicado: (2004)

The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC)
por: Ioannidis, George, et al.
Publicado: (2009)

Corrigendum to “Risk Factors for Fracture in Diabetes: The Canadian Multicentre Osteoporosis Study”
por: Fraser, Lisa-Ann, et al.
Publicado: (2017)

The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
por: Hopkins, Robert B, et al.
Publicado: (2011)

Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study
por: Fraser, Lisa-Ann, et al.
Publicado: (2014)

Optimizing care in osteoporosis: The Canadian quality circle project
por: Ioannidis, George, et al.
Publicado: (2008)

Do patients perceive a link between a fragility fracture and osteoporosis?
por: Giangregorio, Lora, et al.
Publicado: (2008)

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

Validation of a one year fracture prediction tool for absolute hip fracture risk in long term care residents
por: Negm, Ahmed M., et al.
Publicado: (2018)

Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
por: Hiligsmann, Mickaël, et al.
Publicado: (2023)

Atypical fracture of the ulna associated with alendronate use
por: Bjørgul, Kristian, et al.
Publicado: (2011)

Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study
por: Grima, Daniel T, et al.
Publicado: (2010)

Competing interests in development of clinical practice guidelines for diabetes management: Report from a multidisciplinary workshop
por: Sawka, Anna M, et al.
Publicado: (2008)

Associations between Social Isolation Index and changes in grip strength, gait speed, bone mineral density (BMD), and self-reported incident fractures among older adults: Results from the Canadian Longitudinal Study on Aging (CLSA)
por: Lee, Ahreum, et al.
Publicado: (2023)

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial
por: Sawka, Anna M, et al.
Publicado: (2010)

Osteoporotic fractures and obesity affect frailty progression: a longitudinal analysis of the Canadian multicentre osteoporosis study
por: Gajic-Veljanoski, Olga, et al.
Publicado: (2018)

Incorporating Portfolio Uncertainty in Decision Rules for Healthcare Resource Allocation
por: Sendi, Pedram, et al.
Publicado: (2021)

Alendronate and Raloxifene Therapy in the Early Period after Hip Fracture
por: Ohishi, Tsuyoshi, et al.
Publicado: (2011)

Analysis and reporting of stratified cluster randomized trials—a systematic survey
por: Borhan, Sayem, et al.
Publicado: (2020)

Performance of methods for analyzing continuous data from stratified cluster randomized trials – A simulation study
por: Borhan, Sayem, et al.
Publicado: (2023)

Exploring participant attrition in a longitudinal follow-up of older adults: the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort
por: Okpara, Chinenye, et al.
Publicado: (2023)

Analyses of the efficacy of percutaneous kyphoplasty and alendronate sodium on thoracolumbar vertebral fracture and the risk factors of fracture
por: Li, Pengbin, et al.
Publicado: (2018)

Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence
por: Wang, Ke-Meng, et al.
Publicado: (2022)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
por: Iwamoto, Jun, et al.
Publicado: (2010)

Association Among Cognition, Frailty, and Falls and Self‐Reported Incident Fractures: Results From the Canadian Longitudinal Study on Aging (CLSA)
por: Lee, Ahreum, et al.
Publicado: (2022)

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis
por: Foster, Shonda A, et al.
Publicado: (2013)

Effects of pentoxifylline and alendronate on fracture healing in ovariectomy-induced osteoporosis in rats
por: Vashghani Farahani, Mohammad-Mahdi, et al.
Publicado: (2019)

Association between alendronate and atypical femur fractures: a meta-analysis
por: Liu, Lu, et al.
Publicado: (2015)

Meta-regression analysis of the efficacy of alendronate for prevention of glucocorticoid-induced fractures
por: Qiu, Mei, et al.
Publicado: (2020)

Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]
Publicado: (2022)

The development of a decision aid to elicit treatment preferences for displaced femoral neck fractures
por: Alolabi, Bashar, et al.
Publicado: (2012)

An empirical comparison of methods for analyzing over-dispersed zero-inflated count data from stratified cluster randomized trials
por: Borhan, Sayem, et al.
Publicado: (2020)

Self-management program versus usual care for community-dwelling older adults with multimorbidity: A pragmatic randomized controlled trial in Ontario, Canada
por: Fisher, Kathryn, et al.
Publicado: (2020)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures [Expression of concern]
Publicado: (2018)

Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis
por: Fraser, Lisa-Ann, et al.
Publicado: (2011)

Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
por: Gudena, Ravindra, et al.
Publicado: (2011)

Spontaneous Subtrochanteric Femoral Stress Fracture Related to Alendronate : A Case Report
por: Chew, Paul CC, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tbus0sfbl5p03to6turfo74rbi